Cited by 456Iron Metabolism and DisordersFerroptosis and cancer prognosisTelomeres, Telomerase, and Senescence

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index; none of the 92 sources its claims cite is checked for support yet.

Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis

Open access

Abstract

Cellular senescence is characterised by the irreversible arrest of proliferation, a pro-inflammatory secretory phenotype and evasion of programmed cell death mechanisms. We report that senescence alters cellular iron acquisition and storage and also impedes iron-mediated cell death pathways. Senescent cells, regardless of stimuli (irradiation, replicative or oncogenic), accumulate vast amounts of intracellular iron (up to 30-fold) with concomitant changes in the levels of iron homeostasis proteins. For instance, ferritin (iron storage) levels provided a robust biomarker of cellular senescence, for associated iron accumulation and for resistance to iron-induced toxicity. Cellular senescence preceded iron accumulation and was not perturbed by sustained iron chelation (deferiprone). Iron accumulation in senescent cells was driven by impaired ferritinophagy, a lysosomal process that promotes ferritin degradation and ferroptosis. Lysosomal dysfunction in senescent cells was confirmed through several markers, including the build-up of microtubule-associated protein light chain 3 (LC3-II) in autophagosomes. Impaired ferritin degradation explains the iron accumulation phenotype of senescent cells, whereby iron is effectively trapped in ferritin creating a perceived cellular deficiency. Accordingly, senescent cells were highly resistant to ferroptosis. Promoting ferritin degradation by using the autophagy activator rapamycin averted the iron accumulation phenotype of senescent cells, preventing the increase of TfR1, ferritin and intracellular iron, but failed to re-sensitize these cells to ferroptosis. Finally, the enrichment of senescent cells in mouse ageing hepatic tissue was found to accompany iron accumulation, an elevation in ferritin and mirrored our observations using cultured senescent cells.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Senescent cells, regardless of senescence stimulus or cell type, accumulate large amounts of intracellular iron and show impaired ferritinophagy/lysosomal dysfunction, which traps iron in ferritin and renders them resistant to ferroptosis. Promoting ferritin degradation with rapamycin averts the iron-accumulation phenotype but does not re-sensitize senescent cells to ferroptosis.

Key findings

  • Senescent cells accumulated intracellular iron across models: irradiated and replicative MEFs showed ~20-fold increases, oncogene-induced senescent MEFs ~4.5-fold; human irradiated diploid fibroblasts ~3.6-fold, irradiated prostate epithelial cells ~8.4-fold, replicative fibroblasts ~3.3-fold, and replicative prostate epithelial cells ~7.3-fold. With 40 µM ferric ammonium citrate, senescent MEFs accumulated up to ~30-fold more iron than primary MEFs in basal medium.
  • Ferritin was elevated more than 10-fold in senescent MEFs and was also increased in senescent human fibroblasts, prostate epithelial cells, and replicative senescent MEFs; TfR1 was increased, ferroportin localized intracellularly, IRP1 and ISCU were lower, and IRP2 was elevated. Ferritin was proposed as a robust biomarker of senescence and associated iron accumulation.
  • Senescence preceded iron accumulation; sustained deferiprone prevented iron and ferritin accumulation in irradiated MEFs but did not inhibit senescence development, and once iron was stored in established senescent cells it was highly resistant to chelation.
  • Senescent MEFs showed impaired ferritinophagy and lysosomal dysfunction, including failure of deferoxamine to degrade ferritin, build-up of LC3-II and p62, and marked resistance to erastin- and RSL3-induced ferroptosis. Rapamycin averted increases in TfR1, ferritin, and intracellular iron but did not restore ferroptosis sensitivity.
  • In aged mouse liver, SA-βgal-positive senescent cells increased ~10-fold, iron increased ~2.6-fold, and ferritin and p16 were elevated; ferritin-enriched cells (~10%) corresponded with SA-βgal-positive senescent cells (~11%).

Methods

  • Primary mouse embryonic fibroblasts, human diploid fibroblasts, and human prostate epithelial cells were used; senescence was induced by 10 Gy gamma irradiation, replicative exhaustion, or H-RasV12 retroviral transduction. Aged wild-type C57BL/6 mice were compared at 3 months versus 30 months.
  • Main assays included SA-βgal staining, western blotting and densitometry, ICP-MS for total intracellular/tissue iron, qRT-PCR for p16, immunohistochemistry for ferritin, and propidium iodide flow cytometry for viability after erastin/RSL3 treatment.
  • Statistical analyses used two-tailed unpaired t-tests with data as mean ± SD; significance was set at P < 0.05.

Limitations

  • The paper states that future studies are required to determine physiological and pathological roles of iron accumulation in senescent cells, and that the mechanism(s) underlying senescent-cell resistance to ferroptosis are under further investigation.
  • The paper notes that rapamycin preserved ferritinophagy but failed to re-sensitize senescent cells to ferroptosis, indicating other overriding factors are likely involved.
  • Evident from the text: most mechanistic work is in cultured cells, with in vivo evidence limited to aged mouse liver; aged-mouse comparisons used small groups (n = 3–4), and oncogene-induced senescence represented only ~50% of the cell population.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.redox.2017.08.015

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 92 cited sources checked · 0 supported · 0 flagged

Show all 77 claims

  • It may state two separate claims as one. 59
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 36
76 of 76
  • The paper relies on this without support.

    The cell culture models of senescence (irradiation, replicative exhaustion, oncogenic HRasV12) represent cellular senescence as it occurs in vivo.

    “Senescent cells, regardless of stimuli (irradiation, replicative or oncogenic), accumulate vast amounts of intracellular iron (up to 30-fold) with concomitant changes in the levels of iron homeostasis proteins.”
    “Taken together, these results demonstrate that intracellular iron accumulates in senescent cells irrespective of stimuli, or cell origin (mouse vs. human; fibroblast vs. epithelial) and is therefore possibly a universal feature.”
  • The paper relies on this without support.

    Total intracellular iron measured by ICP-MS reflects the iron pool relevant to ferroptosis and iron-induced toxicity.

    “ICP-MS analyses demonstrated that senescent MEFs (MEF IR) accumulated intracellular iron (~ 20-fold) at 21 days post-irradiation (10 Gy).”
    “senescent MEFs (14 days post-irradiation) were substantially less vulnerable to iron induced toxicity than primary non-irradiated MEFs (MEF PRI) (Fig. 4F).”
  • The paper relies on this without support.

    How senescent cells exert adverse effects is poorly understood.

    “However, how senescent cells exert adverse effects is poorly understood.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Opposite lysosomal conditions said to inhibit ferritin degradation

    Minor

    The Fig. 5 caption says lysosomal acidification inhibited ferritin degradation, whereas the Results text says inhibition occurred when the lysosome was alkalinised.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 100 references

Cited by

Sorted by citations

Items 101–200 of 456

Metadata

Authors
Masaldan, S., Clatworthy, S. A. S., Gamell, C., Meggyesy, P. M., Rigopoulos, A.-T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P. A., Bush, A. I., & Cater, M. A.
Affiliations
  • Deakin University (AU)
  • Peter MacCallum Cancer Centre (AU)
  • The University of Melbourne (AU)
Corresponding author
Cater, Michael A.
Venue
Redox Biology
Publisher
Elsevier BV
Published
2018-04
Volume
14
Pages
100-115
ISSN
2213-2317 (ISSN-L)
OpenAlex
W2753909435
Cited by
452
References
100
Citations by year
2026: 44 · 2025: 62 · 2024: 84 · 2023: 74 · 2022: 66 · 2021: 57 · 2020: 33 · 2019: 23 · 2018: 9
FWCI
13.70
Type
journal article
Language
en
Open access
Locations
  • Redox Biology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
Funders
Deakin University
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
cellular senescence, iron accumulation, ferritinophagy, ferroptosis, iron homeostasis, ferritin degradation, lysosomal dysfunction, autophagy, rapamycin, transferrin receptor 1, iron chelation, deferiprone
MeSH terms
Animals, Cell Survival, Cells, Cultured, Ferritins, Fibroblasts, Humans, Iron, Lysosomes, Mice, Inbred C57BL, Mass Spectrometry, Cellular Senescence, Apoptosis, Cyclin-Dependent Kinase Inhibitor p16, NIH 3T3 Cells, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review